Procalcitonin: Evaluation of Antibiotic use in COVID-19 Hospitalised patients. @UniversityLeeds and @CTRCardiffUni
Joined November 2020
- Tweets 84
- Following 34
- Followers 108
- Likes 85
9 Photos and videos
Pinned Tweet
10 Jun 2024
Latest publication from β¦@PEACH_Study1β©
Cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study | Journal of Antimicrobial Chemotherapy | Oxford Academic academic.oup.com/jac/advanceβ¦
3
4
358
PEACH retweeted
5 Nov 2025
Delighted that the final study synopsis for @PEACH_Study1 has now been published in @NIHRresearch library! Full report and results in the 'related links' here: cardiff.ac.uk/centre-for-triβ¦
@CTRCardiffUni @CarrolEnitan @j_sandoe @UniversityLeeds
2
3
248
11 Sep 2024
π₯π₯π₯MAIN RESULTSπ₯π₯π₯
The PEACH team are delighted to finally share the main results of this study!
@CarrolEnitan @j_sandoe @emma_tj1 @Dr_JoanneEuden @LBrookesHowell @DetelinaGrozeva @CTRCardiffUni @UniversityLeeds and many others.
academic.oup.com/jac/advanceβ¦
11
11
627
PEACH retweeted
Great to share our work on @PEACH_Study1 on #procalcitonin shortening antibiotic course length during #Covid #ECCMID2024 or #ESCMIDGlobal
4
8
678
PEACH retweeted
@PEACH_Study1 is an excellent example of using diagnostics to reduce inappropriate antibiotics use during a viral pandemic outbreak @glgamr #eccmid2024 #escmidglobal
25 Apr 2024
Last day of (usual) work before I head to Barcelona tomorrow for @ESCMID. Looking forward to seeing some colleagues and presenting the results of @PEACH_Study1 with @emma_tj1.
2
7
258
27 Apr 2024
And we are here @ESCMID about to go to a sepsis talk by Mervyn Singer and then present the results of our @PEACH_Study1.
1
2
9
240
21 Mar 2024
π₯RESULTS π₯
We are delighted to finally share the results of our PEACH study.
Did procalcitonin tests affect antibiotic prescribing for early COVID-19... youtu.be/iLAjfJ562cc?feature⦠via @YouTube
@NIHRresearch @j_sandoe @CarrolEnitan @CTRCardiffUni @UniversityLeeds #AMS #AMR
1
10
17
932
8 Mar 2024
Weβre looking forward to presenting results of the @PEACH_Study1 at @ECCMID in Barcelona next month. Thank you to everyone who was involved.
@j_sandoe @CarrolEnitan @emma_tj1 @Dr_JoanneEuden @DetelinaGrozeva @WMaboshe @LBrookesHowell Josie Henley, Phil Pallmann & many more!
1
2
9
185
19 Dec 2023
First published findings from @PEACH_Study1 qualitative work stream today in @BMJ_Open.
bmjopen.bmj.com/content/13/1β¦
@josie_henley @LBrookesHowell @Dr_JoanneEuden @j_sandoe @emma_tj1 @CarrolEnitan @CTRCardiffUni @UniversityLeeds @NIHRresearch
1
11
24
2,736
PEACH retweeted
24 Nov 2023
Itβs the end of #WAAW2023 & weβve been highlighting work from our infections division at @CTRCardiffUni. #AMR & antimicrobial stewardship needs to be at forefront of our minds. We need better diagnostics, implemented quickly once evidence exists for better patient outcomes.
4
10
433
PEACH retweeted
22 Nov 2023
Tackling AMR Together π€π
Collaboration is key in fighting AMR. Discover the united efforts in our #WAAW2023 blog.
πblogs.cardiff.ac.uk/centre-fβ¦
@ResearchWales @CUBLSResearch @UKCTUNetwork @TreialonCymru @kerryhood @DPMRes @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan
5
4
398
21 Nov 2023
We have just about finished analysis for @PEACH_Study1 (Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients). Make sure you follow for updates, results and dissemination activities. #WAAW2023
@CarrolEnitan @j_sandoe @NIHRresearch @UniversityLeeds
1
2
6
459
18 Nov 2023
As well as our @PEACH_Study1, see what other studies @CTRCardiffUni are conducting on diagnosis of infections.
Antimicrobial resistance is an urgent global threat. It is vital that we #KeepAntibioticsWorking
@j_sandoe @CarrolEnitan
18 Nov 2023
ππThis #WAAW2023, learn how @CTRCardiffUni is contributing to research on antimicrobial resistance (AMR).
Our World Antimicrobial Resistance Awareness Week blog:
πblogs.cardiff.ac.uk/centre-fβ¦
@ResearchWales @UKCTUNetwork @Pronto_Trial @PEACH_Study1 @BATCH_trial @CarrolEnitan
2
3
373
22 Sep 2023
Alot of work ongoing in the background to get manuscripts submitted. We have an incredibly rich repository of clinical data which reflects the huge effort from all our participating Trusts. We look forward to sharing the results of this study with you over the next few months.
2
4
702
14 Sep 2023
We have finished all analysis. We hope to have main results of @PEACH_Study1 published very soon alongside our qualitative and health economics papers.
cardiff.ac.uk/centre-for-triβ¦
@j_sandoe @CarrolEnitan @AntibioticLeeds @MartinLlewelyn @LBrookesHowell @emma_tj1 @Dr_JoanneEuden
1
8
16
1,186
24 Aug 2023
Thank you to all our sites for participating in the close down process. All sites are now closed.
Analysis of data is almost complete and we look forward to sharing the results in due course.
5
118
19 May 2023
Looking forward to presenting the results of our study at an internal @CTRCardiffUni meeting this week with @CarrolEnitan, and with our wider investigator group next month. Thank you again to all site staff who worked so hard to gather patient data for this study. #ICTD2023
1
5
327
PEACH retweeted
19 May 2023
Tomorrow is #ICTD2023 and a great way to roll into next week when we discuss results of @PEACH_Study1, @BATCH_trial, @PRECISE_study and finalise plans for our first PROTECT stakeholder meeting in Leeds with @CarrolEnitan and @CTRCardiffUni colleagues.
3
5
414
3 Mar 2023
Thank you to our sites for your cooperation during the close down process. Half have officially been closed. We are continuing to analyse our main work package and will publish our results within the next couple of months.
1
3
78
PEACH retweeted
6 Jan 2023
βIt was admirable that the team were committed to such early involvement.β - Margaret, co-applicant
Learn more about how the @PEACH_Study1Β involved public contributors and how those involved found the experience: nihr.ac.uk/documents/case-stβ¦
ALT βI joined PEACH as a co-applicant pre-submission for funding. It was admirable that the team were committed to such early involvement.β - Margaret, co-applicant
5
8
887